Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001007:Anxiety; D001291:Attitude of Health Personnel; D001590:Benztropine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008884:Milieu Therapy; D009069:Movement Disorders / Q000139:chemically induced; D009497:Neurotic Disorders; D010555:Personality Inventory; D012559:Schizophrenia / Q000188:drug therapy*
D000978:Antiparkinson Agents; D001590:Benztropine; D006220:Haloperidol